Current Pharmaceutical Design
Title: Editorial [Hot Topic: Nanomedicine and Drug Delivery (Executive Editors: A.V. Kabanov and K. Levon)]
Volume: 12 Issue: 36
Author(s): Alexander V. Kabanov and Kalle Levon
Affiliation:
Export Options
About this article
Cite this article as:
Kabanov V. Alexander and Levon Kalle, Editorial [Hot Topic: Nanomedicine and Drug Delivery (Executive Editors: A.V. Kabanov and K. Levon)], Current Pharmaceutical Design 2006; 12 (36) . https://dx.doi.org/10.2174/138161206779026290
DOI https://dx.doi.org/10.2174/138161206779026290 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pieces of the Complex Puzzle of Cancer Cell Energy Metabolism: An Overview of Energy Metabolism and Alternatives for Targeted Cancer Therapy
Current Medicinal Chemistry Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy
Current Pharmaceutical Design Arsenic Trioxide in Hematological Malignancies: The New Discovery of an Ancient Drug
Current Pharmaceutical Biotechnology Chemoradiotherapy in Locally Advanced, Unresectable Non-Small Cell Lung Cancer
Reviews on Recent Clinical Trials Cell Death Targeting Therapies in B Lymphoid Malignancies
Current Drug Targets Proteomics to Study Candida albicans Biology and Pathogenicity
Infectious Disorders - Drug Targets DNA Tetraplex-Binding Drugs Structure-Selective Targeting is Critical for Antitumour Telomerase Inhibition
Mini-Reviews in Medicinal Chemistry Nicotinamide Phosphoribosyltransferase as a Target in Inflammation- Related Disorders
Current Topics in Medicinal Chemistry Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics
Recent Patents on Anti-Cancer Drug Discovery Peeking into the Black Box: How Cytokine Antibody Arrays Shed Light on Molecular Mechanisms of Breast Cancer Development and its Treatment
Current Proteomics Chronic Eosinophilic Leukemia, Not Otherwise Specified (CEL, NOS)
Current Cancer Therapy Reviews Improving the Targeting of Tubulin-Binding Agents: Lessons from Drug Resistance Studies
Current Pharmaceutical Design Transition Metal-Based Prodrugs for Anticancer Drug Delivery
Current Medicinal Chemistry Patent Selections:
Recent Patents and Topics on Imaging (Discontinued) Eosinophils in Cancer: Favourable or Unfavourable?
Current Medicinal Chemistry Novel Targets and Derived Small Molecule Inhibitors in Multiple Myeloma
Current Cancer Drug Targets A Possible Approach for Stem Cell Gene Therapy of Fanconi Anemia
Current Gene Therapy Advances in Interleukin-12 Gene Therapy for Acquired Liver Diseases
Current Gene Therapy Cytotoxicity and Target Modulation in Pediatric Solid Tumors by the Proteasome Inhibitor Carfilzomib
Current Cancer Drug Targets Review of Clinic Trials: Agents Targeting c-Met
Reviews on Recent Clinical Trials